{"id":5451,"date":"2022-12-12T14:20:00","date_gmt":"2022-12-12T14:20:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/"},"modified":"2025-07-18T13:23:42","modified_gmt":"2025-07-18T11:23:42","slug":"medtech-technologie-en-type-1-diabetes","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/","title":{"rendered":"MedTech: technologie en type 1 diabetes &#8211; 9 maart 2023"},"content":{"rendered":"<h3 class=\"wp-block-heading\">Technologie is van levensbelang bij type 1 diabetes. Tijdens MedTech op donderdag 9 maart 2023 bespraken we de nieuwste ontwikkelingen op het gebied van type 1 diabetes.<\/h3><p>Medtech is een online avond die je eenvoudig volgt vanaf je computer, tablet of telefoon. Tijdens MedTech gingen alle aanwezigen in online rooms in gesprek met makers van diabetestechnologie. Dit webinar is daarom niet openbaar terug te kijken.<br \/><\/p><h3>MedTech werd mede mogelijk gemaakt door:<\/h3>\n<figure><img decoding=\"async\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/V5-MedTech-sponsoren-2023-3.jpg\" alt=\"\" \/><\/figure>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Technologie is van levensbelang bij type 1 diabetes. Tijdens MedTech op donderdag 9 maart 2023 bespraken we de nieuwste ontwikkelingen op het gebied van type 1 diabetes. Medtech is een online avond die je eenvoudig volgt vanaf je computer, tablet of telefoon. Tijdens MedTech gingen alle aanwezigen in online rooms in gesprek met makers van [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5452,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187,182,190,234],"tags":[],"class_list":["post-5451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-behandelen","category-evenementen","category-kunstmatige-alvleesklier","category-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Technologie is van levensbelang bij type 1 diabetes. Tijdens MedTech op donderdag 9 maart 2023 bespraken we de nieuwste ontwikkelingen op het gebied van type 1 diabetes. Medtech is een online avond die je eenvoudig volgt vanaf je computer, tablet of telefoon. Tijdens MedTech gingen alle aanwezigen in online rooms in gesprek met makers van [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T14:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-18T11:23:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"MedTech: technologie en type 1 diabetes &#8211; 9 maart 2023\",\"datePublished\":\"2022-12-12T14:20:00+00:00\",\"dateModified\":\"2025-07-18T11:23:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\"},\"wordCount\":74,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png\",\"articleSection\":[\"Behandelen\",\"Evenementen\",\"Kunstmatige alvleesklier\",\"Medtech\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\",\"name\":\"MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png\",\"datePublished\":\"2022-12-12T14:20:00+00:00\",\"dateModified\":\"2025-07-18T11:23:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MedTech: technologie en type 1 diabetes &#8211; 9 maart 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/","og_locale":"nl_NL","og_type":"article","og_title":"MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D","og_description":"Technologie is van levensbelang bij type 1 diabetes. Tijdens MedTech op donderdag 9 maart 2023 bespraken we de nieuwste ontwikkelingen op het gebied van type 1 diabetes. Medtech is een online avond die je eenvoudig volgt vanaf je computer, tablet of telefoon. Tijdens MedTech gingen alle aanwezigen in online rooms in gesprek met makers van [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/","og_site_name":"Breakthrough T1D","article_published_time":"2022-12-12T14:20:00+00:00","article_modified_time":"2025-07-18T11:23:42+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png","type":"image\/png"}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"MedTech: technologie en type 1 diabetes &#8211; 9 maart 2023","datePublished":"2022-12-12T14:20:00+00:00","dateModified":"2025-07-18T11:23:42+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/"},"wordCount":74,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png","articleSection":["Behandelen","Evenementen","Kunstmatige alvleesklier","Medtech"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/","name":"MedTech: technologie en type 1 diabetes - 9 maart 2023 - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png","datePublished":"2022-12-12T14:20:00+00:00","dateModified":"2025-07-18T11:23:42+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2022\/12\/Medtech-2023-3.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/medtech-technologie-en-type-1-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"MedTech: technologie en type 1 diabetes &#8211; 9 maart 2023"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5451"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5451\/revisions"}],"predecessor-version":[{"id":6632,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5451\/revisions\/6632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media\/5452"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}